Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17

Hisakazu Nishimori, Yoshinobu Maeda, Takanori Teshima, Haruko Sugiyama, Koichiro Kobayashi, Yoshiko Yamasuji, Sachiyo Kadohisa, Hidetaka Uryu, Kengo Takeuchi, Takehiro Tanaka, Tadashi Yoshino, Yoichiro Iwakura, Mitsune Tanimoto

Blood (2012) 119 (1): 285–295.

https://doi.org/10.1182/blood-2011-01-332478

Published: 2012

Includes: Supplemental data

Journal Articles

Prevention of Idiopathic Pneumonia Syndrome by Intra-Bone Marrow Injection of Donor Cells

Yoshiko Yamasuji, Hisakazu Nishimori, Haruko Sugiyama, Koichiro Kobayashi, Sachiyo Okamoto, Eisei Kondo, Nobuharu Fujii, Katsuji Shinagawa, Takuro Kanekura, Mitsune Tanimoto, Yoshinobu Maeda

Blood (2011) 118 (21): 1902.

https://doi.org/10.1182/blood.V118.21.1902.1902

Published: 2011

Journal Articles

Donor Th17 and Th1 Contribute to Chronic Graft-Versus-Host Disease

Hisakazu Nishimori, Haruko Sugiyama, Koichiro Kobayashi, Yoshiko Yamasuji, Sachiyo Kadohisa, Kengo Takeuchi, Mitsune Tanimoto, Yoshinobu Maeda

Blood (2010) 116 (21): 727.

https://doi.org/10.1182/blood.V116.21.727.727

Published: 2010

Journal Articles

Synthetic Retinoid Am80 Ameliorates Chronic Graft-Versus-Host Disease.

Hisakazu Nishimori, MD, Haruko Sugiyama, MD, Koichiro Kobayashi, MD, Yoshiko Yamasuji, MD, Eisei Kondo, MD, PhD, Katsuji Shinagawa, MD, PhD, Mitsune Tanimoto, MD, PhD, Kengo Takeuchi, MD, PhD, Yoshinobu Maeda, MD, PhD

Blood (2009) 114 (22): 4487.

https://doi.org/10.1182/blood.V114.22.4487.4487

Published: 2009

Journal Articles

Cyclosporine, but Not mTOR Inhibitors, Hampers the Reconstitution of Bone Marrow-Derived Tregs in Long-Term Complete Donor chimeras .

Haruko Sugiyama, MD, Yoshinobu Maeda, MD, Hisakazu Nishimori, MD, Koichiro Kobayashi, MD, Miyuki Nishie-Kataoka, MD, Takanori Teshima, MD, Mitsune Tanimoto, MD

Blood (2008) 112 (11): 2331.

https://doi.org/10.1182/blood.V112.11.2331.2331

Published: 2008

Journal Articles

Unrelated Cord Blood Transplantation after Nonmyeloablative Conditioning: Single Institutional Retrospective Comparison with Bone Marrow or Peripheral Blood Stem-Cell Transplants.

Koichiro Kobayashi, MD, Yoshinobu Maeda, MD, Hisakazu Nishimori, MD, Haruko Sugiyama, MD, Kazutoshi Aoyama, MD, Tomoko Kikuchi, MD, Noriko Namba, MD, Shiro Kubonishi, MD, Masami Niiya, MD, Katsuji Shinagawa, MD, Kazuma Ikeda, MD, Mitsune Tanimoto, MD

Blood (2008) 112 (11): 1967.

https://doi.org/10.1182/blood.V112.11.1967.1967

Published: 2008

NARROW

Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17

Prevention of Idiopathic Pneumonia Syndrome by Intra-Bone Marrow Injection of Donor Cells

Donor Th17 and Th1 Contribute to Chronic Graft-Versus-Host Disease

Synthetic Retinoid Am80 Ameliorates Chronic Graft-Versus-Host Disease.

Cyclosporine, but Not mTOR Inhibitors, Hampers the Reconstitution of Bone Marrow-Derived Tregs in Long-Term Complete Donor chimeras .

Unrelated Cord Blood Transplantation after Nonmyeloablative Conditioning: Single Institutional Retrospective Comparison with Bone Marrow or Peripheral Blood Stem-Cell Transplants.

Email alerts

ASH Publications

American Society of Hematology

Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17

Prevention of Idiopathic Pneumonia Syndrome by Intra-Bone Marrow Injection of Donor Cells

Donor Th17 and Th1 Contribute to Chronic Graft-Versus-Host Disease

Synthetic Retinoid Am80 Ameliorates Chronic Graft-Versus-Host Disease.

Cyclosporine, but Not mTOR Inhibitors, Hampers the Reconstitution of Bone Marrow-Derived Tregs in Long-Term Complete Donor chimeras .

Unrelated Cord Blood Transplantation after Nonmyeloablative Conditioning: Single Institutional Retrospective Comparison with Bone Marrow or Peripheral Blood Stem-Cell Transplants.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only